Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rangering i aksjer #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Aksjekurs
$0.089
Sist synkronisert: 2026-08-17
Markedsverdi
$15.36M
Endring (1 dag)
50.59%
Endring (1 år)
111.85%
Land
US
Handel Inhibitor Therapeutics, Inc. (INTI)

Kategori

Aksjeprishistorikk for Inhibitor Therapeutics, Inc. (INTI)
Høyeste sluttskurs: $0.08 den 2026-08-01

Laveste sluttskurs: $13.64 den 2003-09-01
Aksjeprishistorikk for Inhibitor Therapeutics, Inc. fra 2003 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 36.71%
2025 -32.43%
2024 -25.17%
2023 28.96%
2022 -48.45%
2021 273.68%
2020 -20.00%
2019 -55.15%
2018 -60.33%
2017 -30.61%
2016 198.81%
2015 -0.18%
2014 51.76%
2013 -99.13%
2004 -21.95%
2003 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE